Clinical trial

Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid Tumours

NCT00475956

Study summary

ClinicalTrials.gov

Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid Tumours

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention AZD2171 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention AZD0530 Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2007-05-01

PhasePHASE1

Conditions

Neoplasmsunresolved

Interventions

AZD2171DRUG

AZD0530DRUG

Sponsors & collaborators

AstraZenecalead sponsor

Mapped research locations

Freiburg im BreisgauBaden-Wurttemberg, Germany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00475956 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.